跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
LK-1
首页
药物
LK-1
LK-1
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
GENETICALLY DEFINED IMMUNE-CHECKPOINT INHIBITOR RESISTANCE IN AGGRESSIVE PRECURSORS OF HPV--HEAD AND NECK SQUAMOUS CANCER
US 20260116976 A1
申请人: THE REGENTS OF THE UNIV OF CALIFORNIA
优先权: 2022
US
WO
2 件公开
Selected cationic diazo compounds, compositions comprising them as direct dye, methods for dyeing keratin fibres and kit
EP 1634926 A1
申请人: OREAL
优先权: 2004
EP
EP 1619220 A1
申请人: OREAL D I P I L
优先权: 2004
EP
EP 1619221 A1
申请人: OREAL
优先权: 2004
EP
DRUG-PROTEIN CONJUGATES
EP 3159013 A1
申请人: POLYTHERICS LTD
优先权: 2012
EP
Proteolysis targeting chimera (PROTACS) as degraders of SMARCA2 and /or SMARCA4
US 12187719 B2
申请人: BOEHRINGER INGELHEIM INT
优先权: 2018
US
AMHRII-BINDING ANTIBODY DRUG CONJUGATES AND THEIR USE THEREOF IN THE TREATMENT OF CANCERS
EP 3789401 A1
申请人: GAMAMABS PHARMA
优先权: 2019
EP
Corn protein-derived dipeptide LK and use thereof
CN 111187335 A
申请人: ZHEJIANG ACAD AGRICULTURAL SCI
优先权: 2019
CN
A DRUG CONJUGATE AND APPLICATIONS THEREOF
US 2023256108 A1
申请人: GENEQUANTUM HEALTHCARE SUZHOU CO LTD
优先权: 2019
US
Separation and purification method and application of high-purity geniposide
CN 116854755 A
申请人: UNIV CHINA AGRICULTURAL
优先权: 2022
CN
TATR: MODELING A TARGET AND TIMED-RELEASE STRATEGY FOR TRKB AGONIST DRUG DELIVERY TO COCHLEAR BONE
WO 2025081157 A1
申请人: UNIV SOUTHERN CALIFORNIA
优先权: 2023
WO
Leech polypeptide composition with anti-carotid atherosclerosis effect and application thereof
CN 117843724 A
申请人: BINZHOU MEDICAL COLLEGE
优先权: 2023
CN
第 1 / 2 页
上一页
下一页
药物
反馈